<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24652" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Major Basic Protein</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mussad</surname>
            <given-names>Shiab</given-names>
          </name>
          <aff>Michigan State University College of Human Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dourra</surname>
            <given-names>Mohsen</given-names>
          </name>
          <aff>Michigan State University College of Human Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thandra</surname>
            <given-names>Krishna C.</given-names>
          </name>
          <aff>Chesapeake Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shiab Mussad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohsen Dourra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Krishna Thandra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24652.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Major basic protein (MBP) is an eosinophil granule protein. Eosinophil granules contain a crystalloid core comprised of MBP and a matrix consisting of other toxic and pro-inflammatory mediators. MBP is the predominant constituent in eosinophil granules. MBP derives its name from research in guinea pig eosinophils that showed MBP was the majority protein in secondary granules. Increased concentrations of MBP and other cationic proteins have shown correlations with atopic diseases, parasitic infections, and other eosinophil-associated inflammatory processes.</p>
      </sec>
      <sec id="article-24652.s2" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>MBP is a 13.8 kDa protein rich in arginine with an isoelectric point (pI) of 11.4.<xref ref-type="bibr" rid="article-24652.r1">[1]</xref><xref ref-type="bibr" rid="article-24652.r2">[2]</xref>&#x000a0;The cationic properties of MBP have a link to many of its essential functions. Studies of MBP mRNA have shown that MBP is synthesized from a pre-proform. The pre-portion serves as a signal sequence. The pro-portion is highly acidic and rich in glutamic acid.<xref ref-type="bibr" rid="article-24652.r3">[3]</xref>&#x000a0;Some studies have suggested it may play a role in protecting eosinophils from damage during protein processing&#x000a0;from the Golgi apparatus to secondary granules.<xref ref-type="bibr" rid="article-24652.r4">[4]</xref>&#x000a0;</p>
        <p>The MBP proform (proMBP) is absent in mature eosinophils. The exact trigger for cleavage of proMBP to MBP is not known.&#x000a0;Interleukin-5 (IL-5) is known to stimulate the maturation of eosinophils within the bone marrow and serve as a chemotaxis agent at sites of inflammation. IL-5 also stimulates the synthesis of proteins in eosinophil granules.&#x000a0;</p>
        <p>Studies of IL-5 stimulated umbilical cord precursor cells identified a homolog of MBP named MBP2.<xref ref-type="bibr" rid="article-24652.r4">[4]</xref>&#x000a0;Both proteins have similar molecular masses, but with a pI of 8.7, MBP2 has a much lower positive charge than MBP.<xref ref-type="bibr" rid="article-24652.r4">[4]</xref><bold>&#x000a0;</bold>Although MBP is present in eosinophils, basophils, and other cells, MBP2 has, so far, only been identified in eosinophils, making it a potentially useful biomarker for eosinophilic disorders.<xref ref-type="bibr" rid="article-24652.r4">[4]</xref>&#x000a0;MBP and MBP2 have similar biological effects, at least in vitro, despite their differences in cell localization and pI. &#x000a0;</p>
      </sec>
      <sec id="article-24652.s3" sec-type="Organ Systems Involved">
        <title>Organ Systems Involved</title>
        <p>Eosinophil-mediated diseases involving the lungs, heart, skin, and gut are the best studied and characterized.<xref ref-type="bibr" rid="article-24652.r5">[5]</xref> However, almost any tissue or organ can be affected:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal</p>
          </list-item>
          <list-item>
            <p>Pulmonary&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Renal</p>
          </list-item>
          <list-item>
            <p>Neurologic</p>
          </list-item>
          <list-item>
            <p>Skin</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24652.s4" sec-type="Function">
        <title>Function</title>
        <list list-type="order">
          <list-item>
            <p>Host defense against parasitic infections, such as <italic toggle="yes">Trichinella spiralis </italic>and <italic toggle="yes">Schistosoma mansoni.</italic><xref ref-type="bibr" rid="article-24652.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Activation of mast cells, basophils, and neutrophils during inflammation.<xref ref-type="bibr" rid="article-24652.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Complement activation through alternative and classical pathways.<xref ref-type="bibr" rid="article-24652.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Platelet agonist<xref ref-type="bibr" rid="article-24652.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Antibacterial activity<xref ref-type="bibr" rid="article-24652.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Natural protein inhibitor of heparanase&#x000a0;- heparanase has been implicated in inflammation and inflammation-associated cancer due to its ability to degrade the extracellular matrix scaffold and potentially assist with penetration of eosinophils into other tissues.<xref ref-type="bibr" rid="article-24652.r11">[11]</xref><xref ref-type="bibr" rid="article-24652.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>Additional&#x000a0;functions more closely associated with pathologic activity, such as fibrosis, bronchospasm, and epithelial remodeling, are detailed in subsequent sections.</p>
      </sec>
      <sec id="article-24652.s5" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>MBP is toxic to helminths, bacteria, and mammalian cells. MBP can exert cytotoxic effects through several pathways. It&#x000a0;is capable of increasing membrane permeability, disrupting a cell&#x02019;s lipid bilayer<bold><italic toggle="yes">.</italic></bold><xref ref-type="bibr" rid="article-24652.r13">[13]</xref><xref ref-type="bibr" rid="article-24652.r14">[14]</xref>&#x000a0;MBP also increases histamine release by stimulating mast cells and basophils. Additionally, it can enhance superoxide formation in alveolar macrophages.<xref ref-type="bibr" rid="article-24652.r14">[14]</xref></p>
        <p>MBPs participate in host defense and inflammation via another&#x000a0;distinct method: extracellular DNA traps.<xref ref-type="bibr" rid="article-24652.r15">[15]</xref>&#x000a0;Eosinophil extracellular traps (EETs) are an innate immune mechanism, and they form from cell-released DNA, which combines with eosinophil granule proteins, including MBP, to form a&#x000a0;web that is capable of binding and destroying bacteria.<xref ref-type="bibr" rid="article-24652.r14">[14]</xref><xref ref-type="bibr" rid="article-24652.r15">[15]</xref>&#x000a0;The exact role of MBP and other eosinophil granule proteins in EETs is still under active investigation. Of note, extracellular traps also form by neutrophils (where they were first characterized in 2004), basophils, and lymphocytes. &#x000a0;</p>
        <p>MBP&#x000a0;can influence nerve activity, as well. MBP is an allosteric antagonist of inhibitory M2 receptors.<xref ref-type="bibr" rid="article-24652.r16">[16]</xref> The role of eosinophils and MBP in stimulating bronchial hyperreactivity is a well-characterized phenomenon. MBP and other eosinophil granules are responsible for enhancing vagally induced bronchospasm.<xref ref-type="bibr" rid="article-24652.r16">[16]</xref>&#x000a0;M2 muscarinic receptors in vagal nerves in the lung inhibit the release of acetylcholine, which is responsible for bronchoconstriction. The blockade of inhibitory M2 receptors by MBP leads to increased release of acetylcholine and bronchial hyperreactivity. Studies have shown that neutralization of MBP with polyanionic substances or with antibodies to MBP is able to prevent M2 receptor dysfunction and bronchospasm.<xref ref-type="bibr" rid="article-24652.r16">[16]</xref></p>
      </sec>
      <sec id="article-24652.s6" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Organ and tissue-specific damage due to eosinophil dysfunction or hyperactivity occurs through a variety of methods. MBP is heavily involved in these processes. Four general mechanisms&#x000a0;can describe&#x000a0;the pathology seen in eosinophilic disorders<xref ref-type="bibr" rid="article-24652.r5">[5]</xref>:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p><bold>Eosinophilic infiltration:</bold> Excessive accumulation of eosinophils in tissue can lead to tissue damage if there is extensive deposition. This condition may occur in eosinophilic types of pneumonia, for example.<xref ref-type="bibr" rid="article-24652.r5">[5]</xref><xref ref-type="bibr" rid="article-24652.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p><bold><bold>Allergic inflammation:&#x000a0;</bold></bold>As previously mentioned, IL-5 is vital for its role in stimulating the differentiation and growth of eosinophils and for stimulating their recruitment to sites of inflammation. Th2 cells are highly associated with allergic conditions and can stimulate eosinophils directly or indirectly. Direct stimulation can occur with the Th2 release of IL-5. Indirect activation can occur with Th2 production of IgE, which can bind mast cells (type I hypersensitivity response). Release of mast cell contents, such as Il-5 and leukotrienes, can lead to further eosinophil activation and inflammation.</p>
          </list-item>
          <list-item>
            <p><bold>Fibrosis:</bold> Eosinophils can cause fibrosis by releasing transforming growth factor <italic toggle="yes">&#x003b2;,</italic>&#x000a0;interleukin 4, and interleukin 13, leading to fibroblast activation and proliferation.<xref ref-type="bibr" rid="article-24652.r18">[18]</xref>&#x000a0;Eosinophils can also release granular contents, such as MBP and eosinophil peroxidase (EPO), to stimulate epithelial cells to express fibrosis-inducing factors, a mechanism employed in bronchial epithelial cells that contributes to airway remodeling.<xref ref-type="bibr" rid="article-24652.r19">[19]</xref>&#x000a0;Researchers have also identified MBP for its&#x000a0;role in promoting muscle fibrosis in muscular dystrophy, endomyocardial fibrosis, eosinophilic esophagitis, and other conditions.<xref ref-type="bibr" rid="article-24652.r20">[20]</xref><xref ref-type="bibr" rid="article-24652.r21">[21]</xref><xref ref-type="bibr" rid="article-24652.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Thrombosis:</bold> Eosinophil granular contents can induce a hypercoagulable state in certain diseases by activating platelets. MBP and EPO are potent platelet agonists.<xref ref-type="bibr" rid="article-24652.r9">[9]</xref>&#x000a0;This action is evident in conditions such as thrombotic microangiopathy of the kidney in association with hypereosinophilic syndrome.<xref ref-type="bibr" rid="article-24652.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24652.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Linking clinical symptoms or diseases to eosinophils can, at times, be especially challenging, because eosinophils may not always be present on histopathological or microscopic examination of specimens. This situation can occur due to the degranulation of eosinophil contents at target sites without direct infiltration of eosinophils. As a result, testing for MBP and granular proteins has increased. &#x000a0;</p>
        <p><bold>Skin: </bold>Atopic dermatitis is associated with elevations of serum IgE and eosinophilia in blood. However, biopsies of patients with atopic dermatitis are absent of eosinophils. An analysis of skin tissue via immunofluorescence from affected patients revealed the presence of MBP, suggesting degranulation of MBP from eosinophils in the dermis of patients with atopic dermatitis.<xref ref-type="bibr" rid="article-24652.r22">[22]</xref> These findings further emphasize that eosinophil involvement cannot be excluded simply because of their absence on biopsy, since the release of granule contents, such as MBP, can still occur.</p>
        <p>MBP has also been found in skin biopsies of patients with chronic urticaria.<xref ref-type="bibr" rid="article-24652.r23">[23]</xref>&#x000a0;Other skin conditions associated with general eosinophilia include eosinophilic cellulitis and bullous pemphigoid.<xref ref-type="bibr" rid="article-24652.r5">[5]</xref></p>
        <p><bold>Gastrointestinal: </bold>Eosinophilia and MBP have correlated with various gastrointestinal conditions, such as eosinophilic esophagitis, celiac disease, inflammatory bowel disease, and eosinophilic gastroenteritis.<xref ref-type="bibr" rid="article-24652.r24">[24]</xref>&#x000a0;In a study of patients with eosinophilic esophagitis, biopsies were taken for histological&#x000a0;examination and evaluation&#x000a0;for the presence of MBP by staining with indirect immunofluorescence.<xref ref-type="bibr" rid="article-24652.r25">[25]</xref>&#x000a0;MBP deposition in eosinophilic esophagitis was found in all studied symptomatic patients and showed a correlation with symptom severity independent of eosinophil counts. Similar to atopic dermatitis, eosinophils likely release their granule contents and lose their morphological identity when&#x000a0;specimens are examined.<xref ref-type="bibr" rid="article-24652.r25">[25]</xref>&#x000a0;</p>
        <p><bold>Upper and lower airways: </bold>MBP has implications in bronchial hyperreactivity (reviewed in &#x0201c;mechanisms&#x0201d;). The measurement of this granule in the sputum of patients with asthma has been shown in some studies to be better at identifying asthma than measurement of eosinophilia alone.<xref ref-type="bibr" rid="article-24652.r26">[26]</xref>&#x000a0;Upper airway eosinophilic involvement includes conditions such as chronic rhinosinusitis, especially with associated nasal polyposis.<xref ref-type="bibr" rid="article-24652.r27">[27]</xref></p>
        <p><bold>Cardiovascular: </bold>MBP is deposited in the cardiac tissue of patients with the eosinophilic endomyocardial disease.<xref ref-type="bibr" rid="article-24652.r21">[21]</xref>&#x000a0;Evaluation of cardiac tissue biopsies stained for MBP found eosinophils and MBP in necrotic and thrombotic lesions within the endocardium and blood vessels,&#x000a0;demonstrating the involvement of MBP and other granule proteins in triggering cardiac injury in endomyocardial fibrosis.<xref ref-type="bibr" rid="article-24652.r21">[21]</xref>&#x000a0;Endomyocardial fibrosis is considered the most common restrictive cardiomyopathy in the world. It is clinically comparable to Loeffler endocarditis, another restrictive cardiomyopathy caused by eosinophil infiltration. Vascular dysfunction has also been associated with eosinophilia and includes disorders such as eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).</p>
      </sec>
      <sec id="article-24652.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24652&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24652">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24652/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24652">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24652.s9">
        <fig id="article-24652.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Eosinophilic esophagitis https://commons.wikimedia.org/wiki/File:Multi_ring_esophagus.jpg
Samir at the English language Wikipedia [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0/)]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Multi_ring_esophagus" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24652.s10">
        <fig id="article-24652.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Transmission electron microscope image of a thin section cut through an Eosinophil. Eosinophils contain eosinophil granules that are large (0.1-1.0 micron) spherical, membrane-bound structures, containing a dense and lamellated crystalloid core. Contributed from Louisa Howard; http://remf.dartmouth.edu/images/humanBloodCellsTEM/source/1.html (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Eosinophil_TEM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24652.s11">
        <title>References</title>
        <ref id="article-24652.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Loegering</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Spillard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Weiler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein.</article-title>
            <source>Immunol Lett</source>
            <year>2001</year>
            <month>Oct</month>
            <day>01</day>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-81</page-range>
            <pub-id pub-id-type="pmid">11578692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oxvig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Sottrup-Jensen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein.</article-title>
            <source>FEBS Lett</source>
            <year>1994</year>
            <month>Mar</month>
            <day>21</day>
            <volume>341</volume>
            <issue>2-3</issue>
            <fpage>213</fpage>
            <page-range>213-7</page-range>
            <pub-id pub-id-type="pmid">8137941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Pease</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Acidic precursor revealed in human eosinophil granule major basic protein cDNA.</article-title>
            <source>J Exp Med</source>
            <year>1988</year>
            <month>Oct</month>
            <day>01</day>
            <volume>168</volume>
            <issue>4</issue>
            <fpage>1493</fpage>
            <page-range>1493-8</page-range>
            <pub-id pub-id-type="pmid">3171483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popken-Harris</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McGrogan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Loegering</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Checkel</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Sottrup-Jensen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snable</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein.</article-title>
            <source>J Immunol</source>
            <year>1995</year>
            <month>Aug</month>
            <day>01</day>
            <volume>155</volume>
            <issue>3</issue>
            <fpage>1472</fpage>
            <page-range>1472-80</page-range>
            <pub-id pub-id-type="pmid">7543523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akuthota</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Weller</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of Eosinophilic End-Organ Manifestations.</article-title>
            <source>Immunol Allergy Clin North Am</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>403</fpage>
            <page-range>403-11</page-range>
            <pub-id pub-id-type="pmid">26209892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wassom</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1979</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>860</fpage>
            <page-range>860-3</page-range>
            <pub-id pub-id-type="pmid">484767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogasawara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Furuno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Edamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Peptides of major basic protein and eosinophil cationic protein activate human mast cells.</article-title>
            <source>Biochem Biophys Rep</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>21</volume>
            <fpage>100719</fpage>
            <pub-id pub-id-type="pmid">32072023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Edens</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil granule cationic proteins regulate the classical pathway of complement.</article-title>
            <source>Immunology</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-9</page-range>
            <pub-id pub-id-type="pmid">7750997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rohrbach</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Wheatley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Slifman</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Activation of platelets by eosinophil granule proteins.</article-title>
            <source>J Exp Med</source>
            <year>1990</year>
            <month>Oct</month>
            <day>01</day>
            <volume>172</volume>
            <issue>4</issue>
            <fpage>1271</fpage>
            <page-range>1271-4</page-range>
            <pub-id pub-id-type="pmid">2212954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehrer</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Szklarek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ganz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hamann</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.</article-title>
            <source>J Immunol</source>
            <year>1989</year>
            <month>Jun</month>
            <day>15</day>
            <volume>142</volume>
            <issue>12</issue>
            <fpage>4428</fpage>
            <page-range>4428-34</page-range>
            <pub-id pub-id-type="pmid">2656865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Temkin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aingorn</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Puxeddu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Goldshmidt</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Zcharia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Vlodavsky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Levi-Schaffer</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>703</fpage>
            <page-range>703-9</page-range>
            <pub-id pub-id-type="pmid">15100677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meirovitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hermano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Elkin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Heparanase in inflammation and inflammation-associated cancer.</article-title>
            <source>FEBS J</source>
            <year>2013</year>
            <month>May</month>
            <volume>280</volume>
            <issue>10</issue>
            <fpage>2307</fpage>
            <page-range>2307-19</page-range>
            <pub-id pub-id-type="pmid">23398975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleine</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium.</article-title>
            <source>Am J Physiol</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>275</volume>
            <issue>1</issue>
            <fpage>C93</fpage>
            <page-range>C93-C103</page-range>
            <pub-id pub-id-type="pmid">9688839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharya</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil granule proteins: form and function.</article-title>
            <source>J Biol Chem</source>
            <year>2014</year>
            <month>Jun</month>
            <day>20</day>
            <volume>289</volume>
            <issue>25</issue>
            <fpage>17406</fpage>
            <page-range>17406-15</page-range>
            <pub-id pub-id-type="pmid">24802755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Yousefi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Extracellular DNA traps in allergic, infectious, and autoimmune diseases.</article-title>
            <source>Allergy</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-16</page-range>
            <pub-id pub-id-type="pmid">23409745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacoby</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Fryer</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor.</article-title>
            <source>J Clin Invest</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>1314</fpage>
            <page-range>1314-8</page-range>
            <pub-id pub-id-type="pmid">8473484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrington</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Addington</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Goff</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Madoff</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwaber</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Gaensler</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Chronic eosinophilic pneumonia.</article-title>
            <source>N Engl J Med</source>
            <year>1969</year>
            <month>Apr</month>
            <day>10</day>
            <volume>280</volume>
            <issue>15</issue>
            <fpage>787</fpage>
            <page-range>787-98</page-range>
            <pub-id pub-id-type="pmid">5773637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramirez</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Yacoub</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ripa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mannina</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cariddi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saporiti</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ciceri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Castagna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dagna</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Eosinophils from Physiology to Disease: A Comprehensive Review.</article-title>
            <source>Biomed Res Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9095275</fpage>
            <pub-id pub-id-type="pmid">29619379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;gorier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Pretolani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells.</article-title>
            <source>J Immunol</source>
            <year>2006</year>
            <month>Oct</month>
            <day>01</day>
            <volume>177</volume>
            <issue>7</issue>
            <fpage>4861</fpage>
            <page-range>4861-9</page-range>
            <pub-id pub-id-type="pmid">16982928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wehling-Henricks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sokolow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Myung</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Villalta</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Tidball</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.</article-title>
            <source>Hum Mol Genet</source>
            <year>2008</year>
            <month>Aug</month>
            <day>01</day>
            <volume>17</volume>
            <issue>15</issue>
            <fpage>2280</fpage>
            <page-range>2280-92</page-range>
            <pub-id pub-id-type="pmid">18430716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tai</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Spry</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Dunnette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.</article-title>
            <source>Lancet</source>
            <year>1987</year>
            <month>Mar</month>
            <day>21</day>
            <volume>1</volume>
            <issue>8534</issue>
            <fpage>643</fpage>
            <page-range>643-7</page-range>
            <pub-id pub-id-type="pmid">2882081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leiferman</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Haugen</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Venencie</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.</article-title>
            <source>N Engl J Med</source>
            <year>1985</year>
            <month>Aug</month>
            <day>01</day>
            <volume>313</volume>
            <issue>5</issue>
            <fpage>282</fpage>
            <page-range>282-5</page-range>
            <pub-id pub-id-type="pmid">3892296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Schroeter</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kephart</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Localization of eosinophil granule major basic protein in chronic urticaria.</article-title>
            <source>J Invest Dermatol</source>
            <year>1983</year>
            <month>Jul</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-43</page-range>
            <pub-id pub-id-type="pmid">6345685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Talley</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Kephart</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>McGovern</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease.</article-title>
            <source>Gastroenterology</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>137</fpage>
            <page-range>137-45</page-range>
            <pub-id pub-id-type="pmid">1612323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peterson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gleich</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Limaye</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Crispin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Saffari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clayton</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Leiferman</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts.</article-title>
            <source>Dis Esophagus</source>
            <year>2019</year>
            <month>Dec</month>
            <day>30</day>
            <volume>32</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">31310661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kita</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.</article-title>
            <source>J Asthma</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>10</issue>
            <fpage>994</fpage>
            <page-range>994-1000</page-range>
            <pub-id pub-id-type="pmid">22022864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24652.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Zele</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Claeys</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gevaert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Van Maele</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Holtappels</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Van Cauwenberge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bachert</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of chronic sinus diseases by measurement of inflammatory mediators.</article-title>
            <source>Allergy</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>61</volume>
            <issue>11</issue>
            <fpage>1280</fpage>
            <page-range>1280-9</page-range>
            <pub-id pub-id-type="pmid">17002703</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
